Menu
Recruiting NCT07293975

Pain Control During Braces Removal Using Transcutaneous Electrical Nerve Stimulation and High-Frequency Vibration

No phase Interventional Orthodontic Pain

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Transcutaneous Electrical Nerve Stimulation (TENS), High-Frequency Vibration.
Who it may be relevant to
Registry conditions: Orthodontic Pain. Basic parameters: 15 years — 35 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Iraq
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Assessment of Transcutaneous Electrical Nerve Stimulation and High-Frequency Vibration for Pain Control During Bracket Debonding: A Clinical Trial Study

Overview

This study aims to find the best method to reduce pain during braces removal. We are comparing transcutaneous electrical nerve stimulation (TENS), high-frequency vibration, and a control group with no additional intervention. People who have completed orthodontic treatment and need their braces removed can take part. Participants will be randomly assigned to one of the three groups. The vibration device will be applied during the braces removal, while TENS will be applied just before the procedure. Before the procedure, participants' anxiety will be measured using the Modified Dental Anxiety Scale (MDAS). During and after the procedure, pain will be assessed using a Visual Analog Scale (VAS) from 0 to 100, and participants will rate their satisfaction using a Numerical Rating Scale (NRS) from 0 to 10. The purpose of this research is to help orthodontists identify the method that makes braces removal less uncomfortable, more tolerable, and more satisfying for patients.

Detailed description

This clinical study aims to evaluate and compare the effectiveness and cost-effectiveness of TENS (Dental Pain Eraser) and high-frequency vibration (SureSmile® VPro™) in reducing discomfort during orthodontic bracket removal, improving patient satisfaction, and optimizing efficiency. The study includes a control group, and results are intended to provide evidence-based guidance for orthodontists to enhance the patient experience during debonding procedures.

Participants will be individuals who have completed fixed orthodontic treatment and are scheduled for bracket removal. Before the procedure, their baseline dental anxiety will be assessed. The assigned intervention will be applied either immediately before (TENS) or during (vibration) the bracket removal session. Participants' experiences of pain and satisfaction will be monitored throughout the procedure. Sex and baseline anxiety will be considered in the analysis to evaluate their influence on outcomes. A cost-effectiveness analysis will be performed to determine the most efficient method among the interventions.

The research will be conducted in a standardized clinical setting, adhering to established bracket removal protocols to ensure participant safety and minimize variability. The procedures will be performed by the same operator following consistent techniques.

This study is designed to generate practical insights into pain management during orthodontic debonding, focusing on participant comfort, satisfaction, and procedural efficiency, without compromising the quality of care. The findings may guide future clinical recommendations and improve patient-centered orthodontic practice.

Interventions

  • Device Transcutaneous Electrical Nerve Stimulation (TENS)
    TENS is applied immediately before orthodontic bracket removal in a single session to reduce pain and improve patient satisfaction.
  • Device High-Frequency Vibration
    High-frequency vibration is applied during orthodontic bracket removal in a single session to reduce pain and improve patient satisfaction.

Primary outcome measures

  • Pain During Orthodontic Debonding Measured by VAS [Time frame: During and immediately after debonding procedure]
Secondary outcome measures (4)
  • Baseline Anxiety [Time frame: Prior to the debonding procedure]
  • Patient Satisfaction [Time frame: immediately post-procedure]
  • Device Application Time [Time frame: Periprocedural (during the debonding session)]
  • Cost-Effectiveness Analysis [Time frame: Periprocedural (during the debonding session) and at immediate post-procedure assessment.]

Eligibility criteria

Inclusion criteria

  • Patients scheduled for fixed orthodontic appliance removal.
  • Permanent dentition present, including both anterior and posterior teeth.
  • Age between 15-35 years.
  • Ability to provide informed consent and comply with study procedures.
  • General health adequate for routine orthodontic care.
  • No history of regular or recent medication intake within the preceding 24 hours, including painkillers, corticosteroids, or anti-flu drugs.

Exclusion criteria

  • Patients with craniofacial anomalies, systemic conditions affecting pain perception, or taking medications influencing nociception.
  • Teeth with extensive restorations or prostheses that prevent standard bracket debonding.
  • Patients with known allergy or contraindication to TENS or vibration devices.
  • Pregnant women.
  • Active periodontal disease, including gingival recession or tooth mobility exceeding Grade I.
  • Excessive gingival overgrowth that may impede debonding or influence study outcomes.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Supportive care

Study locations

Iraq · 1 center
  • College of Dentistry, University of Baghdad — Baghdad

Identifiers

NCT: NCT07293975 · TENS-VIB-PAIN-2025

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗